Study guide
10.3 Capital Budgeting
FACHE Board of Governors Exam in Healthcare Management Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the FACHE Credential 1.2 Current Exam Facts 1.3 Eligibility, Application & Recertification
2 Healthcare Systems & Trends
2.1 Healthcare and Medical Terminology 2.2 Healthcare Trends 2.3 Continuum of Care Levels
3 Healthcare Organizations & Services
3.1 Levels of Service from a Business Perspective 3.2 Types of Healthcare Organizations 3.3 Ancillary and Support Services
4 Integration, Clinicians & Staff Perspectives
4.1 Integration, Competition & Partnerships 4.2 Clinician Roles and Qualifying Criteria 4.3 Staff Perspectives & Evidence-Based Management
5 Patient Perspective & Care Delivery
5.1 Patient vs Provider Perspective 5.2 Access, Quality, Cost & Community 5.3 Care Delivery Models and Access Points
6 Digital Health, Population Health & Prevention
6.1 Digital Health 6.2 Population Health Concepts 6.3 Social Determinants & Preventative Medicine
7 Management Planning & Organizational Systems
7.1 Implementation Planning 7.2 Emergency Preparedness & NIMS 7.3 Organizational Systems & Management Functions
8 Leadership, Teams & Change
8.1 Leadership and Communication Styles 8.2 Team-Building Techniques 8.3 Change Management & Organizational Development
9 Collaboration, DEIJ & Networks
9.1 Stakeholder Collaboration 9.2 DEIJ & Resource Allocation 9.3 Network Structures & Collective Bargaining
10 Financial Accounting & Budgeting
10.1 Financial Accounting and Ratios 10.2 Operating Budgets 10.3 Capital Budgeting
11 Reimbursement, Productivity & Controls
11.1 Reimbursement Methodologies 11.2 Productivity Measures 11.3 Financial Controls
12 Revenue, Business Cases & Capital Finance
12.1 Revenue Generation and Payer Mix 12.2 Business Cases & Financial Decision Impacts 12.3 Asset Management & Financing
13 Philanthropy, Supply Chain & Revenue Cycle
13.1 Philanthropy and Foundations 13.2 Supply Chain Management 13.3 Revenue Cycle
14 HR Laws, Recruitment & Staffing
14.1 HR Laws and Regulations 14.2 Recruitment and Retention 14.3 Staffing Methodologies
15 Performance, Engagement & Compensation
15.1 Performance Management Systems 15.2 Motivation, Development & Engagement 15.3 Compensation and Benefits
16 Workplace Safety, Conflict & Labor Relations
16.1 Employee Safety, Security & Health 16.2 Conflict, Grievances & Selection 16.3 Labor Relations & HR Decision Impacts
17 Job Design, Succession & Coaching
17.1 Job Design 17.2 Succession Planning, Mentorship & Coaching
18 Confidentiality, Compliance & Payment Rules
18.1 Confidentiality and Privacy Laws 18.2 Healthcare Compliance Laws 18.3 Medicare, Medicaid & Third-Party Payment Regulations
19 Accreditation, Patient Rights & Ownership Rules
19.1 Accreditation & Inspection Standards 19.2 Patients' Rights Laws 19.3 Nonprofit vs For-Profit Requirements
20 Regulatory Impacts, Labor Law & M&A
20.1 Regulatory Impact on Executive Decisions 20.2 Collective Bargaining Laws 20.3 Legal Implications of Mergers & Acquisitions
21 Benchmarking, Peer Review & Risk
21.1 Benchmarking & Best Practices 21.2 Medical Staff Peer Review 21.3 Risk Management Programs
22 Improvement Methods & Measurement
22.1 PDSA, Lean & Six Sigma 22.2 Clinical Performance Improvement & Pathways 22.3 Quality Measurement & HCAHPS
23 Utilization, Patient Safety & Quality Impacts
23.1 Utilization Review & Case Management 23.2 Patient Safety Tools 23.3 How Quality Impacts Operations
24 Strategic Planning, Business Planning & Contracts
24.1 Strategic Planning Process 24.2 Business Planning for Services 24.3 Business Contracts
25 Socioeconomic Context, Marketing & Media
25.1 Socioeconomic Environment 25.2 Marketing Principles 25.3 Media, Social Media & Community Relations
26 Negotiation & Business Decision Impacts
26.1 Contract Negotiation 26.2 Business Decision Impacts
27 Health IT Operations, Trends & Regulation
27.1 IT in Business Operations 27.2 Technology Trends & Clinical Applications 27.3 HIPAA Security, HITECH & Interoperability
28 Informatics, IT Impacts & Continuity
28.1 Health Informatics for Operational Decisions 28.2 IT Decision Impacts 28.3 Information Systems Continuity
29 IT Acquisition & Analytics
29.1 IT Selection, Acquisition & Maintenance 29.2 Healthcare Analytics & Clinical Informatics
30 ACHE Ethics, Patient Rights & Ethics Committees
30.1 ACHE Code of Ethics 30.2 Patients' Rights & Responsibilities 30.3 Ethics Committees
31 Diversity, Conflicts of Interest & Research Ethics
31.1 Cultural & Spiritual Diversity 31.2 Conflict of Interest 31.3 Unethical Actions & Human-Subject Research
32 Professional Norms, Ethical Culture & Diversity Statement
32.1 Professional Norms & Standards 32.2 Creating an Ethical Culture 32.3 ACHE Statement on Diversity
33 Governance Theory, Structure & Medical Staff
33.1 Governance Theory 33.2 Governance Structure & Operations 33.3 Medical Staff Structure
34 Board Accountability & Public Policy
34.1 Board Role, Accountability & Fiduciary Duty 34.2 Public Policy & Advocacy
10.3 Capital Budgeting
Key Takeaways Explain This Topic AI
Capital budgeting prioritizes long-lived investments (facilities, equipment, IT, strategy) as a governed portfolio aligned to strategy, safety, and debt capacity
Funding sources—cash, bonds, bank debt, philanthropy, leases, JVs—trade off liquidity, leverage, control, and cost of capital
Financial tools (payback, NPV, IRR, sensitivity) support discretionary projects; mandatory safety/compliance capital may proceed despite weak classic ROI
Depreciation is non-cash but signals capital consumption and future replacement need; age of plant and operating pro formas belong in capital decisions
Value analysis weighs clinical outcomes, lifecycle cost, standardization, access/equity, and alternatives—not purchase price alone
Last updated: August 2026
Capital Budgeting
Quick Answer: Capital budgeting is the process of evaluating, prioritizing, funding, and controlling long-lived investments—facilities, equipment, IT, and strategic ventures. Executives must weigh funding sources , long-term financial and operational implications , depreciation , and value analysis (clinical and financial), not only purchase price. On the FACHE exam (Finance F3), capital decisions are judged by multi-year impact on cash, debt capacity, mission, and risk.
A $40 million OR renovation or $120 million EHR program can shape cost structure and competitive position for a decade. Fellows must run capital as a portfolio under governance—not a political queue of departmental wish lists.
What Counts as Capital
Capital expenditures typically involve assets with useful lives beyond one year and material cost thresholds defined by policy (e.g., equipment over $5,000). Categories include:
- Facilities and infrastructure: towers, ambulatory buildings, HVAC, infrastructure
- Clinical equipment: imaging, robotics, monitors, lab analyzers
- Information technology: EHR, ERP, cybersecurity, telehealth platforms
- Strategic capital: acquisitions, joint ventures, ambulatory network builds
- Routine replacement: beds, sterilizers, fleet—often under-prioritized until failure
Capital vs. operating expense: software subscriptions and some cloud services may be operating (OpEx) under current accounting, even when strategically "big." Executives analyze total cost of ownership (TCO) and cash timing regardless of book classification.
The Capital Budgeting Process
Strategy alignment — Does the request advance approved strategic priorities (access, quality, growth, risk reduction)?
Demand and clinical need — Volume forecasts, condition of existing assets, regulatory/safety requirements, physician alignment.
Options analysis — Replace, renovate, lease, outsource, do nothing, or phased approach.
Financial evaluation — Cash flows, NPV/IRR/payback where quantifiable; cost of capital; sensitivity.
Nonfinancial evaluation — Safety, quality, equity of access, workforce, community benefit, competitive necessity.
Prioritization and portfolio balance — Scorecards, mandatory vs. discretionary, risk, and timing.
Funding decision — Cash, debt, philanthropy, leases, grants, partnerships.
Board/governance approval — Thresholds for management vs. board authorization.
Implementation control — Project managers, change orders, contingency, benefits realization.
Post-completion review — Did volume, cost, and quality benefits materialize?
Funding Sources and Their Implications
Source Pros Cons / long-term implications
Internal cash / reserves No interest; preserves debt capacity Opportunity cost; may drop DCOH and liquidity ratings
Tax-exempt bonds (nonprofit) Lower interest if market access strong Covenants, disclosure, DSCR pressure, multi-decade obligation
Taxable debt / bank loans Flexibility, speed Higher rates; covenants; refinancing risk
Philanthropy / foundations Aligns community support; can reduce debt need Timing uncertainty; donor restrictions; not a substitute for operations
Leases (operating/finance) Conserves upfront cash; technology refresh flexibility Long-term cash commitments; accounting on balance sheet under modern lease standards; may still affect leverage views
- Equipment financing / vendor Matches asset life Costly if not competed; vendor lock-in
- Equity / for-profit capital Growth capital Ownership dilution, return expectations, different governance
- Public grants / governmental Low cost when available Compliance burden, restricted use, political risk
- Joint ventures / partnerships Shared capital and risk Shared control, complex governance, exit risk
Scenario — Ambulatory surgery center. A system can build with cash (DCOH falls from 180 to 140 days), issue bonds (preserves cash but raises debt-to-capitalization and DSCR scrutiny), partner with surgeons (aligns volume but shares margin and control), or lease shell space (faster, less ownership of residual asset). The "cheapest sticker price" is rarely the full decision.
Financial Evaluation Tools
Payback period: years to recover investment from cash inflows—simple, ignores time value and post-payback cash.
Net present value (NPV): present value of cash inflows minus outflows discounted at cost of capital—positive NPV adds economic value under the assumptions.
Internal rate of return (IRR): discount rate that sets NPV to zero—compare to hurdle rate.
Profitability index / benefit-cost: useful when capital is rationed.
Sensitivity and scenario analysis: volume −10%, rate cuts, construction overrun, delayed go-live.
Break-even volume: how many cases or visits to cover fixed capital-related costs.
Trap: Forcing every safety or compliance project to show positive NPV. Some capital is mandatory (fire code, life safety, cybersecurity, failed critical equipment). Portfolio management funds must-dos first, then ranks strategic and ROI projects.
Trap: Optimistic volume in physician-requested equipment without market analysis or medical staff development plans. Capital waste often starts as "the robot will pay for itself" without a realistic case schedule.
Depreciation: Book Reality and Decision Reality
Depreciation allocates the cost of a tangible long-lived asset over its useful life (straight-line is most common in healthcare management discussions; accelerated methods may appear for tax in for-profit settings).
Executive points:
Depreciation is non-cash expense but signals capital consumption —assets wear out and must be replaced.
Under-depreciating culture or deferred replacement creates hidden future capital cliffs .
For DSCR and many coverage calculations, depreciation is added back to earnings because cash was not spent that period—yet free cash must still fund replacements.
Accumulated depreciation and age of plant ratios help boards see how old the asset base is.
New capital increases future depreciation, which pressures operating income even when cash debt service is separate—communicate both cash and accrual views to clinical leaders.
Scenario — Imaging replacement. A 12-year-old CT nears end of life. Book value is low; maintenance costs and downtime are high. Capital request looks expensive, but avoiding replacement risks quality, throughput, and emergency rental costs. Value analysis compares downtime, dose/quality, service contracts, and residual risk—not only NPV of fee-for-service scans in a shifting payment model.
Value Analysis in Capital Decisions
Value analysis (and related value analysis committees for supplies/devices) asks: what clinical and operational value do we get per dollar, with evidence?
For capital equipment and projects:
- Clinical outcomes and safety evidence
- Throughput and access (wait times, OR utilization)
- Staffing implications (does new tech need new competencies or reduce FTE need?)
- Lifecycle costs: maintenance, consumables, upgrades, cybersecurity, utilities, training
- Standardization vs. preference items (physician preference items drive cost variation)
Equity: does the investment improve access for underserved sites or concentrate resources only at the flagship?
Alternatives: refurbished equipment, mobile services, referral partnerships
Governance often uses a capital scoring model : strategic fit, financial return, risk/regulatory necessity, quality/safety, community need—weights set by leadership and board finance committee.
Long-Term Implications Executives Must Stress-Test
Capital decisions lock in:
- Debt service and covenants for years
- Operating costs (staffing a new wing, IT analysts, biomed, utilities)
- Strategic flexibility (or inflexibility if specialized plant cannot be repurposed)
- Competitive position (outpatient shift—investing only in inpatient towers can strand capital)
- Credit rating trajectory affecting future cost of capital
- Mission trade-offs (community benefit capacity if liquidity is drained)
Integration with operating budgets: every major capital approval should include a multi-year operating pro forma —not a one-page purchase order. IT projects especially fail when capital is approved but optimization staffing is not.
Portfolio Prioritization Under Capital Rationing
Few systems can fund all requests. Disciplined executives:
- Separate mandatory , replacement , and strategic/growth pools
- Require completed business cases with owners and KPIs
- Avoid "first to lobby" prioritization
- Revisit multi-year capital plans annually as rates, volumes, and strategy change
- Track benefits realization 12–24 months post go-live
Scenario — System capital committee. Requests total $180M; capacity is $95M cash + debt. Mandatory life safety and EHR security take $40M. Remaining $55M is scored: ambulatory access in a growing suburb scores high on strategy and NPV; a low-volume inpatient unit renovation scores low. Committee defers cosmetic inpatient work and funds ambulatory—aligned with outpatient shift and debt capacity.
Bottom Line for Section 10.3
Capital budgeting evaluates long-lived investments with strategy, risk, and multi-year cash impacts in view. Funding sources (cash, debt, philanthropy, leases, partnerships) each change liquidity, leverage, and control. Depreciation and age-of-plant thinking keep replacement real; value analysis balances clinical evidence and lifecycle cost with financial tools like NPV, IRR, and payback. Fellows govern capital as a portfolio that protects mission and credit strength—not a catalog of isolated purchases.